InsiderTrades.com logo

BHVN Insider Trading

Insider Ownership Percentage: 16.00%
Insider Buying (Last 12 Months): $33,144,832.50
Insider Selling (Last 12 Months): $0.00

Biohaven Insider Trading History Chart

This chart shows the insider buying and selling history at Biohaven by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Biohaven Share Price & Price History

Current Price: $8.92
Price Change: ▼ Price Decrease of -0.037 (-0.41%)
As of 03/20/2026 04:59 PM ET

This chart shows the closing price history over time for BHVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Biohaven Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025George C. ClarkCAOBuy17,000$8.52$144,840.0020,000View SEC Filing Icon  
11/13/2025Gregory H. BaileyDirectorBuy400,000$7.50$3,000,000.002,020,071View SEC Filing Icon  
11/13/2025John W. ChildsDirectorBuy3,333,333$7.50$24,999,997.505,653,904View SEC Filing Icon  
11/13/2025Vlad CoricCEOBuy666,666$7.50$4,999,995.001,195,275View SEC Filing Icon  
3/4/2025John W. ChildsDirectorBuy32,700$30.47$996,369.002,320,571View SEC Filing Icon  
12/30/2024John W. ChildsDirectorBuy29,000$35.94$1,042,260.002,368,741View SEC Filing Icon  
10/2/2024John W. ChildsDirectorBuy21,052$47.50$999,970.0021,052View SEC Filing Icon  
9/24/2024Gregory H. BaileyDirectorBuy5,000$44.19$220,950.001,620,071View SEC Filing Icon  
7/18/2024John W. ChildsDirectorBuy28,400$35.67$1,013,028.002,339,741View SEC Filing Icon  
5/30/2024John W. ChildsDirectorBuy28,000$35.58$996,240.002,311,341View SEC Filing Icon  
5/13/2024John W. ChildsDirectorBuy28,500$35.17$1,002,345.002,283,341View SEC Filing Icon  
4/24/2024Gregory H. BaileyDirectorBuy25,503$39.18$999,207.541,600,071View SEC Filing Icon  
4/22/2024Gregory H. BaileyDirectorBuy48,780$41.00$1,999,980.001,574,568View SEC Filing Icon  
4/22/2024Vlad CoricCEOBuy121,951$41.00$4,999,991.001,788,417View SEC Filing Icon  
12/29/2023Irina AntonijevicDirectorSell11,000$41.79$459,690.002,535View SEC Filing Icon  
10/5/2023Matthew ButenCFOBuy22,727$22.00$499,994.00189,380View SEC Filing Icon  
10/5/2023Vlad CoricCEOBuy113,637$22.00$2,500,014.001,657,031View SEC Filing Icon  
10/4/2023Gregory H. BaileyDirectorBuy17,817$22.57$402,129.691,525,788View SEC Filing Icon  
8/30/2023John W. ChildsDirectorBuy50,000$18.44$922,000.001,975,118View SEC Filing Icon  
8/4/2023John W. ChildsDirectorBuy100,000$19.78$1,978,000.001,925,118View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Biohaven (NYSE:BHVN)

88.78% of Biohaven stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BHVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Biohaven Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/3/2026Caitong International Asset Management Co. Ltd7,192$81K0.0%N/A0.007%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.194,751$2.20M0.0%+59.0%0.184%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV30,316$0.34M0.0%N/A0.029%Search for SEC Filing on Google Icon
2/18/2026Coastal Bridge Advisors LLC24,797$0.28M0.0%-26.6%0.023%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC143,328$1.62M0.0%-8.0%0.135%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd83,455$0.94M0.0%+31.1%0.079%Search for SEC Filing on Google Icon
2/18/2026Ikarian Capital LLC212,481$2.40M0.2%-73.3%0.201%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC1,318,775$14.89M0.1%+758.4%1.246%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC23,072$0.26M0.1%+216.1%0.022%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC110,840$1.25M0.0%-38.0%0.105%Search for SEC Filing on Google Icon
2/18/2026Twinbeech Capital LP11,700$0.13M0.0%N/A0.011%Search for SEC Filing on Google Icon
2/18/2026Suvretta Capital Management LLC10,286,937$116.14M2.4%+83.0%9.718%Search for SEC Filing on Google Icon
2/18/2026Quadrature Capital Ltd52,663$0.60M0.0%+171.9%0.050%Search for SEC Filing on Google Icon
2/18/2026Readystate Asset Management LP651,603$7.36M0.3%+72.8%0.616%Search for SEC Filing on Google Icon
2/18/2026Oxford Asset Management LLP30,694$0.35M0.1%N/A0.029%Search for SEC Filing on Google Icon
2/18/2026Inspire Investing LLC41,150$0.47M0.0%+35.0%0.039%Search for SEC Filing on Google Icon
2/18/2026Ishara Investments LP88,000$0.99M1.1%N/A0.083%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC1,407,365$15.90M0.0%-79.2%1.330%Search for SEC Filing on Google Icon
2/18/2026Eversept Partners LP145,431$1.64M0.1%N/A0.137%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP13,639$0.15M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.1,591,054$17.96M0.0%+317.7%1.503%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC73,077$0.83M0.0%-75.7%0.069%Search for SEC Filing on Google Icon
2/18/20265AM Venture Management LLC738,972$8.34M2.6%+54.3%0.698%Search for SEC Filing on Google Icon
2/18/2026ACT Capital Management LLC7,500$85K0.1%N/A0.007%Search for SEC Filing on Google Icon
2/17/2026Freestone Grove Partners LP25,647$0.29M0.0%N/A0.024%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC34,277$0.39M0.0%-30.5%0.032%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC1,606,777$18.14M0.1%+3,829.9%1.518%Search for SEC Filing on Google Icon
2/17/2026Burkehill Global Management LP500,000$5.65M0.4%N/A0.472%Search for SEC Filing on Google Icon
2/17/2026PDT Partners LLC84,700$0.96M0.1%N/A0.080%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC1,460,108$16.49M0.0%+584.6%1.379%Search for SEC Filing on Google Icon
2/17/2026Infinitum Asset Management LLC6,250,000$70.56M10.2%+267.6%5.904%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC208,987$2.36M0.0%N/A0.197%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP604,182$6.82M0.1%+202.3%0.571%Search for SEC Filing on Google Icon
2/17/2026Amundi10,408$0.12M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC245,891$2.78M0.0%+1,077.8%0.232%Search for SEC Filing on Google Icon
2/17/2026Iron Triangle Partners LP958,336$10.82M1.2%N/A0.905%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD2,018,550$22.79M0.0%+0.4%1.907%Search for SEC Filing on Google Icon
2/17/2026Anson Funds Management LP667,381$7.54M0.7%N/A0.630%Search for SEC Filing on Google Icon
2/17/2026Integral Health Asset Management LLC1,500,000$16.94M0.8%+130.8%1.417%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.150,000$1.69M0.0%-88.1%0.142%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System110,361$1.25M0.0%+37.7%0.104%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.25,826$0.29M0.0%+25.2%0.024%Search for SEC Filing on Google Icon
2/17/2026Atom Investors LP19,356$0.22M0.0%N/A0.018%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board45,598$0.52M0.0%-2.7%0.043%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors23,799$0.27M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP1,192,026$13.46M0.1%+614.4%1.126%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada122,581$1.38M0.0%-12.2%0.116%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.145,852$1.65M0.0%+333.8%0.138%Search for SEC Filing on Google Icon
2/16/2026Mariner LLC48,979$0.56M0.0%+317.7%0.046%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP80,175$0.91M0.0%N/A0.076%Search for SEC Filing on Google Icon
2/16/2026Arax Advisory Partners4,914$55K0.0%+943.3%0.005%Search for SEC Filing on Google Icon
2/13/2026FORA Capital LLC22,951$0.26M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP30,027$0.34M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 133,081$1.53M0.0%-0.9%0.126%Search for SEC Filing on Google Icon
2/13/2026Quinn Opportunity Partners LLC210,326$2.38M0.1%+601.1%0.199%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp9,939,856$112.22M0.1%+50.3%9.390%Search for SEC Filing on Google Icon
2/13/2026Bridgefront Capital LLC38,365$0.43M0.1%N/A0.036%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC209,306$2.36M0.0%+28.0%0.198%Search for SEC Filing on Google Icon
2/13/2026Headlands Technologies LLC35,010$0.40M0.0%N/A0.033%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.847,412$9.57M0.0%+13.0%0.801%Search for SEC Filing on Google Icon
2/13/2026State Street Corp5,716,487$64.54M0.0%+34.2%5.400%Search for SEC Filing on Google Icon
2/13/2026QTR Family Wealth LLC334,833$4.09M1.8%+0.8%0.316%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC163,388$1.85M0.0%N/A0.154%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC574,478$6.49M0.0%+0.4%0.543%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN151,516$1.71M0.0%+35.1%0.143%Search for SEC Filing on Google Icon
2/12/2026Advisors Asset Management Inc.9,197$0.10M0.0%-62.8%0.009%Search for SEC Filing on Google Icon
2/12/2026Orion Porfolio Solutions LLC11,498$0.13M0.0%-29.4%0.011%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC52,569$0.59M0.0%-3.6%0.050%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc8,138$92K0.0%-58.3%0.008%Search for SEC Filing on Google Icon
2/12/2026Steward Partners Investment Advisory LLC65,150$0.74M0.0%+135.6%0.062%Search for SEC Filing on Google Icon
2/12/2026Knott David M Jr110,720$1.25M0.6%N/A0.105%Search for SEC Filing on Google Icon
2/12/2026Swiss National Bank229,200$2.59M0.0%+36.2%0.217%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC731,953$8.26M0.0%+94.5%0.691%Search for SEC Filing on Google Icon
2/11/2026Empowered Funds LLC143,328$1.62M0.0%-8.0%0.135%Search for SEC Filing on Google Icon
2/11/2026Inceptionr LLC36,555$0.41M0.1%N/A0.035%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG138,649$1.57M0.0%+11.4%0.131%Search for SEC Filing on Google Icon
2/11/2026Focus Partners Advisor Solutions LLC10,423$0.12M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/11/2026Fox Run Management L.L.C.25,471$0.29M0.0%-50.7%0.024%Search for SEC Filing on Google Icon
2/11/2026Cerity Partners LLC47,143$0.53M0.0%N/A0.045%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC42,175$0.48M0.0%+8.8%0.040%Search for SEC Filing on Google Icon
2/11/2026Erste Asset Management GmbH693,300$7.85M0.1%+643.1%0.655%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.589,565$6.66M0.0%-55.9%0.557%Search for SEC Filing on Google Icon
2/11/2026Fiera Capital Corp724,551$8.18M0.0%+29.1%0.684%Search for SEC Filing on Google Icon
2/11/2026Capital Research Global Investors1,332,792$15.05M0.0%+31.8%1.259%Search for SEC Filing on Google Icon
2/11/2026WINTON GROUP Ltd64,028$0.72M0.0%+136.3%0.060%Search for SEC Filing on Google Icon
2/10/2026TD Asset Management Inc141,678$1.60M0.0%+4.2%0.134%Search for SEC Filing on Google Icon
2/10/2026BNP Paribas Financial Markets2,093,816$23.64M0.0%+148.2%1.978%Search for SEC Filing on Google Icon
2/10/2026Northwestern Mutual Wealth Management Co.9,152$0.10M0.0%+145.0%0.009%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC67,096$0.76M0.0%+14.5%0.063%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC2,392,277$27.01M0.0%+16.1%2.260%Search for SEC Filing on Google Icon
2/9/2026Simplify Asset Management Inc.958,202$10.82M0.2%+773.6%0.905%Search for SEC Filing on Google Icon
2/6/2026EverSource Wealth Advisors LLC4,031$46K0.0%+178.4%0.004%Search for SEC Filing on Google Icon
2/6/2026Leonteq Securities AG6,935$78K0.0%N/A0.007%Search for SEC Filing on Google Icon
2/6/2026IFP Advisors Inc4,069$46K0.0%+55.4%0.004%Search for SEC Filing on Google Icon
2/6/2026Handelsbanken Fonder AB36,600$0.41M0.0%+34.1%0.035%Search for SEC Filing on Google Icon
2/6/2026Profund Advisors LLC77,279$0.87M0.0%+118.3%0.073%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC17,138$0.19M0.0%+10.8%0.016%Search for SEC Filing on Google Icon
2/5/2026ARS Investment Partners LLC1,239,600$14M0.8%+12.4%1.171%Search for SEC Filing on Google Icon
2/4/2026VIRGINIA RETIREMENT SYSTEMS ET Al133,900$1.51M0.0%+484.7%0.126%Search for SEC Filing on Google Icon
2/2/2026Alpha Wealth Funds LLC19,400$0.21M0.1%N/A0.018%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Biohaven logo
Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. The company's pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors; Taldefgrobep Alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 2/3 clinical trials for the treatment of focal and generalized epilepsy, bipolar disorder, and major depressive disorder; BHV-2100 that is in Phase 1 clinical trials for the treatment of migraines and neuropathic pain; and BHV-8000, a product candidate in Phase 1 clinical trials for the treatment of early Alzheimer's and Parkinson's disease, sclerosis, and amyloid-related imaging abnormalities. It also offers BHV-1300, a product candidate in Phase 1 clinical trials to treat rheumatoid arthritis; BHV-1310 for the treatment of generalized myasthenia gravis and acute exacerbations or flares; BHV-1400 to treat IgA Nephropathy; and BHV-1600 for the treatment of dilated cardiomyopathy. In addition, the company develops BHV-1100, a product candidate in Phase 1a/1b clinical trials for multiple myeloma patients; BHV-1510, a preclinical product that targets carcinomas; and BHV-1500 for Hodgkin's lymphoma. It has license, development, and commercialization agreements with Yale University, AstraZeneca, University of Connecticut, Artizan Biosciences Inc., Reliant Glycosciences LLC, Katholieke Universiteit Leuven, BMS, and Highlightll Pharmaceutical Co. Ltd. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.
Read More on Biohaven

Today's Range

Now: $8.92
Low: $8.85
High: $9.27

50 Day Range

MA: $11.39
Low: $8.96
High: $13.73

52 Week Range

Now: $8.92
Low: $7.48
High: $31.18

Volume

6,124,424 shs

Average Volume

2,674,790 shs

Market Capitalization

$944.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Biohaven?

Biohaven's top insider shareholders include:
  1. John W Childs (Director)
  2. Gregory Bailey (Director)
  3. Vlad Coric (CEO)
  4. George C Clark (CAO)
Learn More about top insider investors at Biohaven.

Who are the major institutional investors of Biohaven?

Biohaven's top institutional shareholders include:
  1. Suvretta Capital Management LLC — 9.72%
  2. Stifel Financial Corp — 9.39%
  3. Infinitum Asset Management LLC — 5.90%
  4. State Street Corp — 5.40%
  5. Vanguard Group Inc. — 4.15%
  6. Geode Capital Management LLC — 2.26%
Learn More about top institutional investors of Biohaven stock.

Which major investors are selling Biohaven stock?

During the last quarter, BHVN stock was sold by these institutional investors:
  1. Janus Henderson Group PLC
  2. Adage Capital Partners GP L.L.C.
  3. JPMorgan Chase & Co.
  4. Vestal Point Capital LP
  5. Ikarian Capital LLC
  6. Caption Management LLC
  7. Boothbay Fund Management LLC
  8. Goldman Sachs Group Inc.

Which major investors are buying Biohaven stock?

During the last quarter, BHVN stock was bought by institutional investors including:
  1. Suvretta Capital Management LLC
  2. Infinitum Asset Management LLC
  3. Stifel Financial Corp
  4. Schonfeld Strategic Advisors LLC
  5. Vanguard Group Inc.
  6. State Street Corp
  7. BNP Paribas Financial Markets
  8. AQR Capital Management LLC
Within the previous year, these company insiders have bought Biohaven stock:
  1. John W Childs (Director)
  2. Gregory Bailey (Director)
  3. Vlad Coric (CEO)
  4. George C Clark (CAO)
Learn More investors buying Biohaven stock.